MGNX vs TECH · rev $149.5M vs P/E 65, rev $1.22B
MacroGenics Inc (MGNX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MGNX revenue for 2025-12-31 was $149.5M. Net income was -$74.6M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. MGNX currently screens at market cap $246.6M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MGNX currently screens at market cap $246.6M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MGNX and TECH stock pages for the full models.
Not investment advice.